Baby boomer men have recently become targets in a new push by drug companies to combat low testosterone. Companies like Lilly and Abbott are introducing testosterone replacement drugs — like Androgel — that promise to restore flagging libidos, enhance energy and even combat depression.
Reporter Shannon Pettypiece wrote about these new testosterone drugs for Bloomberg.
It might sound like another marketing push to sell drugs, but 14 million men in the country do have low testosterone according to Pettypiece, and could benefit from testosterone replacement therapy. The problem is that many men who are taking these drugs may not necessairly need it — which leads to quite a few side effects, like prostate cancer or infertility.
There are already millions of women taking hormone replacement therapy drugs to combat the bad effects of menopause. Is this the real growth area for pharmaceuticals — products that make boomers feel young again?
Shannon Pettypiece, reporter for Bloomberg.